CIK 0001720580
- Non-accelerated filer
- Smaller reporting company
Adicet Bio, Inc.
Sign in to watch- Ticker
- ACET
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 26
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813305277
- Phone
- +1 617-482-2333
- Business address
- 131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
- Former names
- resTORbio, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-27 | MCCABE JOHN J Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +24,600 | 24,600 | ||
| 2018-11-05 | Schor Chen Director | Gift | −6,000 | 325,000 | ||
| 2018-11-05 | Grissinger Michael Director | Grant or award · Stock Option (Right to Buy) | +28,828 | 28,828 | ||
| 2018-10-26 | Mannick Joan Chief Medical Officer | Gift | −600,000 | 1,286,363 | ||
| 2018-10-26 | Mannick Joan Chief Medical Officer | Gift | +600,000 | 600,000 | ||
| 2018-10-15 | Schor Chen Director | Gift | −593,363 | 356,000 | ||
| 2018-10-15 | Schor Chen Director | Gift | −25,000 | 331,000 | ||
| 2018-10-15 | Schor Chen Director | Gift | −643,000 | 943,000 | ||
| 2018-10-15 | Schor Chen Director | Gift | −25,000 | 943,000 | ||
| 2018-09-17 | Manning Meredith Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +175,000 | 175,000 | ||
| 2018-08-14 | Chodakewitz Jeffrey Director | Grant or award · Stock Option (Right to Buy) | +28,828 | 28,828 | ||
| 2018-07-06 | Schor Chen Director | Gift | −943,000 | 949,363 | ||
| 2018-04-16 | Schor Chen President and CEO | Purchase | +2,000 | $8.95 | $18K | 1,892,363 |
| 2018-04-11 | Schor Chen President and CEO | Purchase | +2,000 | $9.36 | $19K | 1,890,363 |
| 2018-04-10 | Schor Chen President and CEO | Purchase | +2,000 | $8.46 | $17K | 1,888,363 |
| 2018-03-13 | MCCABE JOHN J Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +4,603 | 4,603 | ||
| 2018-01-30 | SILVERSTEIN JONATHAN Director | Conversion | +2,425,485 | 2,425,485 | ||
| 2018-01-30 | SILVERSTEIN JONATHAN Director | Conversion | +1,871,569 | 4,297,054 | ||
| 2018-01-30 | SILVERSTEIN JONATHAN Director | Purchase | +533,333 | $15.00 | $8.0M | 4,830,387 |
| 2018-01-30 | SILVERSTEIN JONATHAN Director | Conversion · Series A Preferred Stock | −2,425,482 | 0 |
Page 28 of 29 · 569 trades